Fact CheckerSign in

NCT07149311Completed

Effectiveness of Diabetes Self-management Education on Glycaemic Control in Patients With T2DM

Effectiveness of Diabetes Self-management Education on Diabetes Control in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 29 Aug 2025

Brief summary (registry, in English)

This is a randomized controlled trial assessing the effectiveness of a nurse led diabetes self management education(DSME) given over a 6 month period via mixed delivery strategy (in-person and via phone calls) on Hemoglobin A1c(HbA1c), fasting blood glucose(FBG), blood pressure, body weight and low density lipoprotein cholesterol(LDL-C). The main question this research seeks to answer is 1\. Does diabetes self-management education when combined with usual care improve glycaemic control when compared to usual care alone? Patients will be randomized into intervention and control groups. The intervention group will receive nurse led DSME using the American Association of diabetes educators 7 self care behaviour over a 6 month period. It will involve 3 monthly in-person sessions starting from the first day of recruitment as well as 2 weekly phone call sessions. This will be in addition to the usual care at the diabetes clinic. The control group will receive usual diabetes care

Status (registry)
Completed
Study type
Interventional
Enrollment
74 (actual)
First submitted
2 Jul 2025
Start date
6 Feb 2024
Primary completion date
30 Oct 2024
Lead sponsor
Komfo Anokye Teaching Hospital
NCT number
NCT07149311

What you commit to

  • Study type: Interventional
  • Participants enrolled: 74
  • From 6 Feb 2024 to the primary completion date, 30 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other forms of DM such as type 1 DM or gestational diabetes.
  • History of stroke or other atherosclerotic cardiovascular diseases with impairment which makes the affected individual dependent on others for care giving and precludes self-care

Lab values

  • End-stage renal disease(eGFR\<15ml/min)

Other

  • Anaemia

Who the study is looking for

  • Patients with T2DM who are at least 18 years old without any co-morbidities requiring immediate hospitalisation
  • HbA1c \>7.9%
  • Have access to a personal mobile phone and able to answer calls.
  • Mentally stable, with no vision, verbal, or hearing impairments
  • Have access a glucometer.
  • Consents to the study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Komfo Anokye Teaching Hospital
Coordinator of this site? Confirm its status
KumasiGhanaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.